NRx Pharmaceuticals announces positive safety report for Zyesami in NIH-sponsored ACTIV-3 study in…
ACTIV-3 Critical Care is evaluating Zyesami and Remdesivir in critical COVID-19 patients as monotherapy, and in combination…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.